ethidium has been researched along with Epilepsy, Temporal Lobe in 1 studies
Ethidium: A trypanocidal agent and possible antiviral agent that is widely used in experimental cell biology and biochemistry. Ethidium has several experimentally useful properties including binding to nucleic acids, noncompetitive inhibition of nicotinic acetylcholine receptors, and fluorescence among others. It is most commonly used as the bromide.
ethidium : The fluorescent compound widely used in experimental cell biology and biochemistry to reveal double-stranded DNA and RNA.
Epilepsy, Temporal Lobe: A localization-related (focal) form of epilepsy characterized by recurrent seizures that arise from foci within the TEMPORAL LOBE, most commonly from its mesial aspect. A wide variety of psychic phenomena may be associated, including illusions, hallucinations, dyscognitive states, and affective experiences. The majority of complex partial seizures (see EPILEPSY, COMPLEX PARTIAL) originate from the temporal lobes. Temporal lobe seizures may be classified by etiology as cryptogenic, familial, or symptomatic. (From Adams et al., Principles of Neurology, 6th ed, p321).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conclude that stathmin expression in demyelinating disorders could have a dual role." | 1.33 | Expression of stathmin, a developmentally controlled cytoskeleton-regulating molecule, in demyelinating disorders. ( Bruck, W; Casaccia-Bonnefil, P; Liu, A; Mastronardi, FG; Moscarello, M; Sobel, A; Stadelmann, C, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, A | 1 |
| Stadelmann, C | 1 |
| Moscarello, M | 1 |
| Bruck, W | 1 |
| Sobel, A | 1 |
| Mastronardi, FG | 1 |
| Casaccia-Bonnefil, P | 1 |
1 other study available for ethidium and Epilepsy, Temporal Lobe
| Article | Year |
|---|---|
Expression of stathmin, a developmentally controlled cytoskeleton-regulating molecule, in demyelinating disorders.
Topics: Animals; Apoptosis; Brain; Cell Differentiation; Cells, Cultured; Demyelinating Diseases; Epilepsy, | 2005 |